{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:15:30Z","timestamp":1786979730078,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"DOI":"10.1007\/s00192-021-05072-7","type":"journal-article","created":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T06:02:56Z","timestamp":1642053776000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of intravesical onabotulinumtoxinA (Botox) on sexual function in patients with overactive bladder syndrome: a systematic review and meta-analysis"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4207-9568","authenticated-orcid":false,"given":"Sami","family":"Shawer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aethele","family":"Khunda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth J.","family":"Waring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Ballard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,13]]},"reference":[{"issue":"1","key":"5072_CR1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/nau.20870","volume":"29","author":"P Abrams","year":"2010","unstructured":"Abrams P, Andersson KE, Birder L, et al. Fourth international consultation on incontinence recommendations of the international scientific committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn. 2010;29(1):213\u201340. https:\/\/doi.org\/10.1002\/nau.20870.","journal-title":"Neurourol Urodyn"},{"issue":"6","key":"5072_CR2","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","volume":"50","author":"DE Irwin","year":"2006","unstructured":"Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50(6):1306\u201314; discussion 1314\u20135. https:\/\/doi.org\/10.1016\/j.eururo.2006.09.019.","journal-title":"Eur Urol"},{"issue":"11 Suppl","key":"5072_CR3","first-page":"S580","volume":"6","author":"P Abrams","year":"2000","unstructured":"Abrams P, Kelleher CJ, Kerr LA, Rogers RG. Overactive bladder significantly affects quality of life. Am J Manag Care. 2000;6(11 Suppl):S580\u201390.","journal-title":"Am J Manag Care"},{"issue":"Pt 3","key":"5072_CR4","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1348\/135910705X60742","volume":"11","author":"S Perry","year":"2006","unstructured":"Perry S, McGrother CW, Turner K, Leicestershire MRC Incontinence Study Group. An investigation of the relationship between anxiety and depression and urge incontinence in women: development of a psychological model. Br J Health Psychol. 2006;11(Pt 3):463\u201382. https:\/\/doi.org\/10.1348\/135910705X60742.","journal-title":"Br J Health Psychol"},{"issue":"2","key":"5072_CR5","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1159\/000098066","volume":"78","author":"I Sen","year":"2007","unstructured":"Sen I, Onaran M, Tan MO, Acar C, Camtosun A, Sozen S, Bozkirli I. Evaluation of sexual function in women with overactive bladder syndrome. Urol Int. 2007;78(2):112\u20135. https:\/\/doi.org\/10.1159\/000098066.","journal-title":"Urol Int"},{"issue":"1","key":"5072_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1590\/s1677-55382006000100014","volume":"32","author":"AS Patel","year":"2006","unstructured":"Patel AS, O'Leary ML, Stein RJ, Leng WW, Chancellor MB, Patel SG, Borello-France D. The relationship between overactive bladder and sexual activity in women. Int Braz J Urol. 2006;32(1):77\u201387. https:\/\/doi.org\/10.1590\/s1677-55382006000100014.","journal-title":"Int Braz J Urol"},{"issue":"1","key":"5072_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/SPV.0b013e3181bf51eb","volume":"16","author":"A Zahariou","year":"2010","unstructured":"Zahariou A, Karamouti M, Tyligada E, Papaioannou P. Sexual function in women with overactive bladder. Female Pelvic Med Reconstr Surg. 2010;16(1):31\u20136. https:\/\/doi.org\/10.1097\/SPV.0b013e3181bf51eb.","journal-title":"Female Pelvic Med Reconstr Surg"},{"issue":"1","key":"5072_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1743-6109.2011.02366.x","volume":"9","author":"S Jha","year":"2012","unstructured":"Jha S, Ammenbal M, Metwally M. Impact of incontinence surgery on sexual function: a systematic review and meta-analysis. J Sex Med. 2012;9(1):34\u201343. https:\/\/doi.org\/10.1111\/j.1743-6109.2011.02366.x.","journal-title":"J Sex Med"},{"key":"5072_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.urology.2016.10.026","volume":"100","author":"H L\u00f3pez Ramos","year":"2017","unstructured":"L\u00f3pez Ramos H, Torres Castellanos L, Ponce Esparza I, Jaramillo A, Rodr\u00edguez A, Moreno Bencardino C. Management of overactive bladder with onabotulinumtoxinA: systematic review and meta-analysis. Urology. 2017;100:53\u20138. https:\/\/doi.org\/10.1016\/j.urology.2016.10.026.","journal-title":"Urology"},{"key":"5072_CR10","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535. https:\/\/doi.org\/10.1136\/bmj.b2535.","journal-title":"BMJ"},{"key":"5072_CR11","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hernan MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. https:\/\/doi.org\/10.1136\/bmj.i4919.","journal-title":"BMJ"},{"key":"5072_CR12","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovic J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898.","journal-title":"BMJ"},{"issue":"3","key":"5072_CR13","doi-asserted-by":"publisher","first-page":"1000427","DOI":"10.4172\/2155-9562.1000427","volume":"8","author":"A Giannantoni","year":"2017","unstructured":"Giannantoni A, Gubbiotti M, et al. Effects of Onabotulinum toxin a intradetrusor injections on urinary symptoms and sexual life in women affected by multiple sclerosis: a prospective controlled study. J Neurol Neurophysiol. 2017;8(3):1000427. https:\/\/doi.org\/10.4172\/2155-9562.1000427.","journal-title":"J Neurol Neurophysiol"},{"issue":"12","key":"5072_CR14","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1007\/s00345-015-1578-4","volume":"33","author":"A Giannantoni","year":"2015","unstructured":"Giannantoni A, Proietti S, Giusti G, et al. OnabotulinumtoxinA intradetrusorial injections improve sexual function in female patients affected by multiple sclerosis: preliminary results. World J Urol. 2015;33(12):2095\u2013101. https:\/\/doi.org\/10.1007\/s00345-015-1578-4.","journal-title":"World J Urol"},{"issue":"6","key":"5072_CR15","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1016\/j.juro.2012.12.022","volume":"189","author":"VW Nitti","year":"2013","unstructured":"Nitti VW, Dmochowski R, Herschorn S, et al. OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial. J Urol. 2013;189(6):2186\u201393. https:\/\/doi.org\/10.1016\/j.juro.2012.12.022.","journal-title":"J Urol"},{"issue":"2","key":"5072_CR16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.eururo.2013.04.001","volume":"64","author":"C Chapple","year":"2013","unstructured":"Chapple C, Sievert K-D, MacDiarmid S, et al. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial. Eur Urol. 2013;64(2):249\u201356. https:\/\/doi.org\/10.1016\/j.eururo.2013.04.001.","journal-title":"Eur Urol"},{"issue":"1","key":"5072_CR17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eururo.2012.03.005","volume":"62","author":"CJ Fowler","year":"2012","unstructured":"Fowler CJ, Auerbach S, Ginsberg D, et al. OnabotulinumtoxinA improves health-related quality of life in patients with urinary incontinence due to idiopathic overactive bladder: a 36-week, double-blind, placebo-controlled, randomized, dose-ranging trial. Eur Urol. 2012;62(1):148\u201357. https:\/\/doi.org\/10.1016\/j.eururo.2012.03.005.","journal-title":"Eur Urol"},{"key":"5072_CR18","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejogrb.2018.05.002","volume":"225","author":"M Balzarro","year":"2018","unstructured":"Balzarro M, Rubilotta E, Braga A, et al. OnabotulinumtoxinA detrusor injection improves female sexual function in women with overactive bladder wet syndrome. Eur J Obstet Gynecol Reprod Biol. 2018;225:228\u201331. https:\/\/doi.org\/10.1016\/j.ejogrb.2018.05.002.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"6","key":"5072_CR19","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1002\/nau.23148","volume":"36","author":"P Miotla","year":"2017","unstructured":"Miotla P, Cartwright R, Skorupska K, et al. Impact of intravesical onabotulinumtoxinA on sexual function in women with OAB. Neurourol Urodyn. 2017;36(6):1564\u20139. https:\/\/doi.org\/10.1002\/nau.23148.","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"5072_CR20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/009262300278597","volume":"26","author":"R Rosen","year":"2000","unstructured":"Rosen R, Brown C, Heiman J, et al. The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26(2):191\u2013208. https:\/\/doi.org\/10.1080\/009262300278597.","journal-title":"J Sex Marital Ther"},{"issue":"4","key":"5072_CR21","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.sxmr.2019.05.002","volume":"7","author":"M Balzarro","year":"2019","unstructured":"Balzarro M, Rubilotta E, Mancini V, et al. Impact of overactive bladder-wet syndrome on female sexual function: a systematic review and meta-analysis. Sex Med Rev. 2019;7(4):565\u201374. https:\/\/doi.org\/10.1016\/j.sxmr.2019.05.002.","journal-title":"Sex Med Rev"},{"issue":"1","key":"5072_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.esxm.2019.08.013","volume":"8","author":"G Levy","year":"2020","unstructured":"Levy G, Lowenstein L. Overactive bladder syndrome treatments and their effect on female sexual function: a review. Sex Med. 2020;8(1):1\u20137. https:\/\/doi.org\/10.1016\/j.esxm.2019.08.013.","journal-title":"Sex Med"},{"issue":"1","key":"5072_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12894-018-0377-9","volume":"18","author":"A Zachariou","year":"2018","unstructured":"Zachariou A, Mamoulakis C, Filiponi M, et al. The effect of mirabegron, used for overactive bladder treatment, on female sexual function: a prospective controlled study. BMC Urol. 2018;18(1):61. https:\/\/doi.org\/10.1186\/s12894-018-0377-9.","journal-title":"BMC Urol"},{"issue":"3","key":"5072_CR24","doi-asserted-by":"publisher","first-page":"200","DOI":"10.5301\/RU.2011.8547","volume":"78","author":"A Del Rosso","year":"2011","unstructured":"Del Rosso A, Pace G, Di Pierro ED, Masciovecchio S, Galatioto GP, Vicentini C. Impact of overactive bladder on sexual function in women. Urologia. 2011;78(3):200\u20132. https:\/\/doi.org\/10.5301\/RU.2011.8547.","journal-title":"Urologia"},{"issue":"1","key":"5072_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11255-018-2030-7","volume":"51","author":"SS Cakir","year":"2019","unstructured":"Cakir SS, Degirmentepe RB, Atalay HA, et al. The effect of overactive bladder treatment with anticholinergics on female sexual function in women: a prospective observational study. Int Urol Nephrol. 2019;51(1):27\u201332. https:\/\/doi.org\/10.1007\/s11255-018-2030-7.","journal-title":"Int Urol Nephrol"},{"issue":"4","key":"5072_CR26","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1590\/S1677-5538.IBJU.2016.0303","volume":"43","author":"A Zachariou","year":"2017","unstructured":"Zachariou A, Filiponi M. The effect of extended release tolterodine used for overactive bladder treatment on female sexual function. Int Braz J Urol. 2017;43(4):713\u201320. https:\/\/doi.org\/10.1590\/S1677-5538.IBJU.2016.0303.","journal-title":"Int Braz J Urol"},{"issue":"6","key":"5072_CR27","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1111\/bju.12972","volume":"116","author":"SW Autiero","year":"2015","unstructured":"Autiero SW, Hallas N, Betts CD, Ockrim JL. The cost-effectiveness of sacral nerve stimulation (SNS) for the treatment of idiopathic medically refractory overactive bladder (wet) in the UK. BJU Int. 2015;116(6):945\u201354. https:\/\/doi.org\/10.1111\/bju.12972.","journal-title":"BJU Int"},{"issue":"3","key":"5072_CR28","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00192-018-3841-x","volume":"30","author":"A Khunda","year":"2019","unstructured":"Khunda A, McCormick C, Ballard P. Sacral neuromodulation and sexual function: a systematic review and meta-analysis of the literature. Int Urogynecol J. 2019;30(3):339\u201352. https:\/\/doi.org\/10.1007\/s00192-018-3841-x.","journal-title":"Int Urogynecol J"},{"issue":"8","key":"5072_CR29","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1002\/nau.22251","volume":"31","author":"C Burton","year":"2012","unstructured":"Burton C, Sajja A, Latthe PM. Effectiveness of percutaneous posterior tibial nerve stimulation for overactive bladder: a systematic review and meta-analysis. Neurourol Urodyn. 2012;31(8):1206\u201316. https:\/\/doi.org\/10.1002\/nau.22251.","journal-title":"Neurourol Urodyn"},{"issue":"10","key":"5072_CR30","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1007\/s00192-019-04027-3","volume":"30","author":"V Kershaw","year":"2019","unstructured":"Kershaw V, Khunda A, McCormick C, Ballard P. The effect of percutaneous tibial nerve stimulation (PTNS) on sexual function: a systematic review and meta-analysis. Int Urogynecol J. 2019;30(10):1619\u201327. https:\/\/doi.org\/10.1007\/s00192-019-04027-3.","journal-title":"Int Urogynecol J"},{"issue":"2","key":"5072_CR31","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/AOG.0000000000002733","volume":"132","author":"JM Weinberger","year":"2018","unstructured":"Weinberger JM, Houman J, Caron AT, et al. Female sexual dysfunction and the placebo effect: a meta-analysis. Obstet Gynecol. 2018;132(2):453\u20138. https:\/\/doi.org\/10.1097\/AOG.0000000000002733.","journal-title":"Obstet Gynecol"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-021-05072-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-021-05072-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-021-05072-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T08:02:40Z","timestamp":1643875360000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-021-05072-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,13]]},"references-count":31,"alternative-id":["5072"],"URL":"https:\/\/doi.org\/10.1007\/s00192-021-05072-7","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,13]]},"assertion":[{"value":"24 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Sami Shawer: no conflicts of interest; Aethele Khunda: in the last 5\u00a0years, received educational grants from Medtronic, Olympus, Axonic and speaker fees from Astellas (I also received travel and accommodation expenses from conference organisers when invited as a speaker); Gareth J. Waring: no conflicts of interest; Paul Ballard: in the last 5\u00a0years, received an educational grant from Olympus.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}